Literature DB >> 26105107

Palliative parenteral nutrition use in patients with intestinal failure as a consequence of advanced pseudomyxoma peritonei: a case series.

B R Disney1, A Karthikeyakurup1, J Ratcliffe1, J Jones1, P Deel-Smith1, A Fairhurst2, K Maleki3, S C Cooper4.   

Abstract

Pseudomyxoma peritonei (PMP) is a rare condition complicated by intra-abdominal spread that can cause multilevel gastrointestinal (GI) obstruction. Parenteral nutrition (PN) use in the context of palliative care and malignancy remains controversial. We describe the use of palliative PN in three patients with progressive PMP causing multilevel GI obstruction and intestinal failure. All patients received > 90 days of PN. PN was safe in this cohort of patients. However, patient selection and the timing of intervention are important factors when considering the initiation of PN.

Entities:  

Mesh:

Year:  2015        PMID: 26105107     DOI: 10.1038/ejcn.2015.97

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

1.  The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients.

Authors:  F Bozzetti; L Santarpia; L Pironi; P Thul; S Klek; C Gavazzi; M Tinivella; F Joly; C Jonkers; J Baxter; L Gramlich; L Chicharro; M Staun; A Van Gossum; S Lo Vullo; L Mariani
Journal:  Ann Oncol       Date:  2014-01-09       Impact factor: 32.976

2.  Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience.

Authors:  Daanish Hoda; Aminah Jatoi; Jan Burnes; Charles Loprinzi; Darlene Kelly
Journal:  Cancer       Date:  2005-02-15       Impact factor: 6.860

3.  Is there a role for TPN in terminally ill patients with bowel obstruction?

Authors:  Donald R Duerksen; Ellen Ting; Patti Thomson; Kerri McCurdy; Joanna Linscer; Sheri Larsen-Celhar; Elaine Brennenstuhl
Journal:  Nutrition       Date:  2004-09       Impact factor: 4.008

4.  ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology.

Authors:  F Bozzetti; J Arends; K Lundholm; A Micklewright; G Zurcher; M Muscaritoli
Journal:  Clin Nutr       Date:  2009-05-23       Impact factor: 7.324

5.  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.

Authors:  R M Smeenk; M L F van Velthuysen; V J Verwaal; F A N Zoetmulder
Journal:  Eur J Surg Oncol       Date:  2007-05-23       Impact factor: 4.424

6.  Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?

Authors:  Irit Chermesh; Tania Mashiach; Amnon Amit; Nissim Haim; Irina Papier; Ruthi Efergan; Jesse Lachter; Rami Eliakim
Journal:  Med Oncol       Date:  2010-01-27       Impact factor: 3.064

  6 in total
  1 in total

1.  Enteral nutrition provides favorable postoperative outcomes for patients with pseudomyxoma peritonei: a retrospective study.

Authors:  Xuechun Kuang; Guie She; Yanhui Shi; Zhiyou Yang; Jun Li; Zhipeng Zhang
Journal:  Gland Surg       Date:  2022-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.